Sciencast Management LP lifted its stake in Exelon Co. (NASDAQ:EXC – Free Report) by 18.0% during the fourth quarter, Holdings Channel.com reports. The fund owned 80,864 shares of the company’s stock after buying an additional 12,336 shares during the period. Exelon accounts for approximately 0.8% of Sciencast Management LP’s holdings, making the stock its 14th largest holding. Sciencast Management LP’s holdings in Exelon were worth $3,044,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also bought and sold shares of the company. State Street Corp grew its position in shares of Exelon by 3.7% in the 3rd quarter. State Street Corp now owns 60,169,219 shares of the company’s stock valued at $2,439,862,000 after acquiring an additional 2,156,259 shares during the period. Geode Capital Management LLC increased its position in Exelon by 1.6% during the third quarter. Geode Capital Management LLC now owns 25,945,791 shares of the company’s stock worth $1,048,823,000 after buying an additional 403,542 shares during the last quarter. FMR LLC raised its stake in Exelon by 18.7% in the third quarter. FMR LLC now owns 11,782,549 shares of the company’s stock valued at $477,782,000 after buying an additional 1,858,502 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in shares of Exelon by 1.8% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,967,343 shares of the company’s stock valued at $363,626,000 after buying an additional 160,313 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its position in shares of Exelon by 4.4% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 6,729,004 shares of the company’s stock valued at $253,280,000 after buying an additional 282,596 shares during the last quarter. Institutional investors own 80.92% of the company’s stock.
Wall Street Analyst Weigh In
A number of equities research analysts recently weighed in on EXC shares. Guggenheim upgraded Exelon from a “neutral” rating to a “buy” rating in a research note on Thursday, January 23rd. BMO Capital Markets reissued an “outperform” rating on shares of Exelon in a research report on Tuesday, February 4th. Barclays lifted their target price on shares of Exelon from $42.00 to $48.00 and gave the stock an “overweight” rating in a report on Tuesday, February 25th. Scotiabank increased their price target on shares of Exelon from $42.00 to $44.00 and gave the company a “sector perform” rating in a report on Thursday, February 13th. Finally, Evercore ISI upgraded Exelon from an “in-line” rating to an “outperform” rating and boosted their price objective for the stock from $43.00 to $44.00 in a report on Tuesday, January 21st. Five equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, Exelon currently has a consensus rating of “Moderate Buy” and a consensus target price of $45.13.
Insider Activity at Exelon
In related news, EVP Colette D. Honorable sold 1,463 shares of Exelon stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $40.57, for a total value of $59,353.91. Following the transaction, the executive vice president now directly owns 2,271 shares of the company’s stock, valued at $92,134.47. This trade represents a 39.18 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.10% of the stock is owned by insiders.
Exelon Stock Performance
NASDAQ EXC opened at $43.80 on Friday. Exelon Co. has a 12-month low of $34.01 and a 12-month high of $45.20. The firm has a 50-day moving average price of $41.97 and a two-hundred day moving average price of $39.95. The company has a market capitalization of $44.03 billion, a P/E ratio of 17.88, a P/E/G ratio of 2.86 and a beta of 0.51. The company has a quick ratio of 0.78, a current ratio of 0.87 and a debt-to-equity ratio of 1.61.
Exelon (NASDAQ:EXC – Get Free Report) last issued its quarterly earnings results on Wednesday, February 12th. The company reported $0.64 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.59 by $0.05. Exelon had a return on equity of 9.52% and a net margin of 10.68%. During the same quarter in the prior year, the company earned $0.60 EPS. Analysts anticipate that Exelon Co. will post 2.64 earnings per share for the current year.
Exelon Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Monday, February 24th were given a $0.40 dividend. The ex-dividend date of this dividend was Monday, February 24th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 3.65%. This is a boost from Exelon’s previous quarterly dividend of $0.38. Exelon’s dividend payout ratio (DPR) is presently 65.31%.
Exelon Company Profile
Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.
See Also
- Five stocks we like better than Exelon
- The Significance of Brokerage Rankings in Stock Selection
- FedEx Delivers Another Crushing Blow to Its Stock Price
- How to Buy Cheap Stocks Step by Step
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- Where to Find Earnings Call Transcripts
- Micron Stock Will Retest All-Time Highs This Year
Want to see what other hedge funds are holding EXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exelon Co. (NASDAQ:EXC – Free Report).
Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.